Meghan FitzGerald - 16 Oct 2023 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Director
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Meghan Fitzgerald
Issuer symbol
ROIV
Transactions as of
16 Oct 2023
Net transactions value
$0
Form type
4
Filing time
18 Oct 2023, 21:30:18 UTC
Previous filing
14 Sep 2023
Next filing
23 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Award $0 +1,269 +13% $0.000000 11,358 16 Oct 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date.